US Patent Issued to Takeda Pharmaceutical on June 16 for "Lyophilized recombinant VWF formulations" (Austrian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,867, issued on June 16, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Lyophilized recombinant VWF formulations" was invented by Kurt Schnecker (Vienna), Eva Haidweger (Vienna) and Peter Turecek (Klosterneuberg, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations."

The patent was filed on Oct. 29, 2021, under Application No. 17/514,906.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netac...